SEC Tracker
Get the app

ZeroStack ZSTK

ZeroStack Q3 FY24: revenue $12.5M, down 28%; diluted EPS −$0.28

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers ZeroStack reported for Q3 FY24, the quarter ended Sep 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$12.5M−28% from $17.3M in Q3 FY2310-Q income statement, on EDGAR
  2. Net income−$3.8M−405% from $1.2M in Q3 FY2310-Q income statement, on EDGAR
  3. Diluted EPS−$0.28−275% from $0.16 in Q3 FY2310-Q income statement, on EDGAR
  4. Cash and cash equivalents$4.2M−12% from $4.8M in Q3 FY2310-Q balance sheet, on EDGAR
  5. Cash from operations−$2.1M−502% from $518K in Q3 FY2310-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when ZeroStack files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 6199 and related industry codes: the same peer list as the financial tables.

  1. Marblegate Capital MGTE public float $12M, Jun 30, 2025
  2. Applied Dna Sciences APDN public float $11M, Mar 31, 2025, over 18 months old
  3. HeartSciences HSCS public float $10M, Oct 31, 2025
  4. FG Nexus FGC public float $13M, Jun 30, 2025
  5. Marygold Companies MGLD public float $9M, Dec 31, 2025